Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

May 14, 2024

BUY
$80.24 - $95.27 $1.28 Million - $1.51 Million
15,900 Added 19.25%
98,500 $8.15 Million
Q3 2022

Nov 10, 2022

BUY
$80.24 - $95.27 $1.28 Million - $1.51 Million
15,900 Added 19.25%
98,500 $8.15 Million
Q2 2022

May 14, 2024

BUY
$76.05 - $123.38 $6.28 Million - $10.2 Million
82,600 New
82,600 $6.61 Million
Q1 2022

May 16, 2022

SELL
$108.37 - $120.0 $1.04 Million - $1.15 Million
-9,600 Reduced 10.41%
82,600 $9.34 Million
Q4 2021

Feb 14, 2022

BUY
$94.5 - $116.95 $4.38 Million - $5.43 Million
46,400 Added 101.31%
92,200 $10.5 Million
Q3 2021

Nov 10, 2021

BUY
$116.26 - $133.78 $5.32 Million - $6.13 Million
45,800 New
45,800 $5.33 Million

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $15.8B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.